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optimization criteria for a certain patient regarding election between 
E or PH boost with similar CTV coverage. 
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Purpose/Objective: Head and neck cancer treatment is associated 
with significant morbidities. Both exclusive radiotherapy (RT) and 
chemoradiotherapy (CHRT) treatments can produce, as side effects, 
increased rates of long-term dysphagia. The purpose of the study here 
presented was to evaluate the ability of videofluoroscopy (VDF) in 
detecting and measuring swallowing dysfunction secondary to 
treatments. 
Materials and Methods: Eight head-and-neck cancer patients, who 
underwent radical RT till 70 Gy (5 fractions per week, 2 Gy per 
fraction), and concurrent chemotherapy (CHT) when indicated, were 
included. Treatment schedules administered to each patient (RT total 
dose, radiation fields, delivery techniques, CHT schemes) were 
decided according the NCCN recommendations. Half of patients 
received exclusive RT and the other half concomitant CHRT.  
In order to evaluate a possible swallowing dysfunction, VDF were 
performed before and after the treatment. Patients presenting 
swallowing dysfunction before the treatment were excluded. Post-
treatment evaluation was undertaken twice: early (1-3 months) and 
late post-therapy (4-9 months). The VDF explored swallowing 
dysfunction with the standard different textures. 
Results: Three patients developed some swallowing dysfunction in 
early post-therapy evaluation and, in the late post-therapy 
evaluation, 7 patients showed propulsive defect of the pharynx and 6 
of them had also residue. Only one patient had symptoms related to 
this dysfunction. No case of pneumonia by aspiration was reported. 
Conclusions: Swallowing dysfunction is a prevalent side effect after 
intensive RT and CHRT treatment in head-and-neck cancer patients. In 
our first 8 patients included, most frequent swallowing dysfunction 
was the propulsive defect of the pharynx asymptomatic in most of the 
cases. VDF was very effective in detecting, measuring and controlling 
this side effect. However, in order to confirm these results, inclusion 
of more patients is required. Therefore, patient enrolment continues. 
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Purpose/Objective: In daily clinical practice, acute adverse skin 
reactions due to radiation therapy (RT) are graded by the experienced 
eye of the radiation oncologist. However, such subjective grading 
provides only rough estimates of RT response. In addition, a great 
range of skin reactions is observed even between patients undergoing 
the same treatment. Aim of our study was to implement a 
quantitative method, based on reflectance spectrophotometry (RS), 
for objective in vivo measurements of skin erythema and pigmentation 
due to RT. Correlations between RS measurements and both clinicians' 
skin toxicity perceptions and delivered superficial doses were 
investigated. 
Materials and Methods: Patients treated with tangential fields to the 
breast parenchyma were included. RT prescribed dose: 50-60Gy, 2Gy 
per fraction. Skin RS measurements were obtained by means of a 
commercially available system (SpectroShade, MHT) which allows to 
acquire skin reflectance data between 483 and 950nm inside an useful 
field of view of 18x14mm2. Measurements were performed before RT 
and approximately every 6 (range 4-8) RT fractions up to the end of 
the RT treatment. At the same time, skin acute toxicity grade (ATG) 
reactions were visually assessed and recorded by the physician using 
RTOG scoring system.Both instrumental RS measurement and 
subjective ATG were performed at five different fixed points within 
the area treated with RT. RS relative changes at two selected band 
widths centred at 560nm (haemoglobin absorption peak) and720nm 
(mainly melanin absorption) were analysed and their correlation with 
ATG and delivered superficial dose was investigated. 
Results: Preliminary analysis of measurements at inframammary fold 
on 11 pts is here presented. SkinRS relative changes at 560nm 
(RSRC560nm) were a strong indicator of skin erythema and correlated 
well with clinical ATG evaluation (fig 1a). No evidence of a 
relationship between superficial absorbed doses (at inframammary 
fold) and RSRC560nm was obtained. However, after an initial 30Gy 
irradiation, where patient-to-patient variability to RT resulted to be 
extremely high, RSRC560nm data clearly indicate the existence of 3 
different groups of patients, i.e. over- normal- and under- reacting to 
RT, with RSRC560nm values <0.6 (3pts), in 0.8-0.9 range (6pts) and 
>1.1 (2pts), respectively (fig 1b). Finally, skin RS relative changes at 
720nm (RSRC720nm) resulted to be mostly related to skin 
pigmentation and started to slightly modify at the very end of the RT.  
  
Conclusions: RS is a good and objective tool to evaluate skin 
erythema and pigmentation changes. Although preliminary, these data 
are very interesting and do deserve further investigation. More 
patients will be recruited to investigate the origin of the variation in 
patients' radiosensitivity, at the genetic level. 
This study was funded by a grant of Mrs M. Bonatti and Mr G. Mameli 
and by the National Cancer League 
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Purpose/Objective: This study explores the relationship between the 
severity of late normal tissue damage in the irradiated breast, i.e. 
fibrosis leading to breast shrinkage, and the variation in residual DSBs, 
and in damage response markers (p21 and p53) of dermal fibroblasts 
isolated from skin biopsies of the patient and irradiated in-vivo or in-
vitro. 
Materials and Methods: 35 breast cancer patients with minimal 
(controls) or marked late fibrotic changes in the irradiated breast 
(cases) were selected 5 to 10 years after postoperative radiotherapy 
after breast preserving surgery. Skin biopsies of 4 mm diameter were 
taken 24 h or 12 weeks after irradiation of a field of 4 x 2 cm² in the 
lower back with 4 Gy using 6 MeV electrons. Punch biopsies were 
taken from both the irradiated and the contralateral unirradiated 
skin. Primary fibroblast cultures were established by outgrowth from 
those fresh irradiated and unirradiated skin biopsies which were 
collected 12 weeks after exposure. Residual DSBs were quantified in 
tissue sections from irradiated and unirradiated skin as well as in 
primary fibroblasts cultures which were irradiated in-vitro with 4 Gy 
as well by scoring 53BP1 foci. P53 and p21 levels were measured in 
fibroblast cultures. 
Results: 24 h after in-vitro irradiation the residual number of 53BP1 
foci increased compared to levels in unirradiated fibroblast cultures. 
The increase is larger in fibroblasts isolated from the cases than from 
the control patients. By contrast, the in-vivo irradiated samples which 
were established 12 weeks after irradiation have essentially the same 
number of foci as the unirradiated cells. The expression of p53 is 
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significantly upregulated on day 2 after 4 Gy in-vitro irradiation in 
both groups (approximately 6-fold in controls and 2.5-fold in cases), 
but appears to decay more slowly in fibroblasts from cases. However, 
cases show a significantly higher level of p53 than controls (p=0.0205) 
and this effect independent of any further radiation exposure.  
Conclusions: DNA damage, in particular unrepaired DSB is not a 
significant factor in the development of late breast fibrosis after 
radiotherapy. 
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Purpose/Objective: To validate the hypothesis that: a) The increase 
of esophagus SUVmax one week after the start of radiotherapy 
treatment is correlated with parallel severe dysphagia level (grade ≥ 
2); b) The increase of esophagus SUVmax at one specific level is 
correlated to the dose given at this specific level and c) To investigate 
whether some specific anatomical regions of the esophagus (divided 
into 3 equal parts) are more sensitive to inflammation than others. 
Materials and Methods: A cohort of 39 non-small cell lung cancer 
patients treated with curative intend and having had two FDG PET 
scans: one before treatment and approximately one week after start 
of treatment (average 9 ± 2 days). Dysphagia toxicity, PET and CT 
scans were analyzed for each patient. The esophagus has been divided 
into 3 equal regions: a caudal region (part 1), a middle region (part 2) 
and a cranial region (part 3). 
-The maximal PET-SUV value in the esophagus (SUVmax) was 
computed, excluding the GTV regions, for the whole esophagus and 
for each part of the esophagus on both time points. The change in 
SUVmax, ΔSUVmax, was calculated. This change was correlated to the 
incidence of severe dysphagia (grade ≥2).  
-The patients were divided into 2 groups: one group (Gr 2) consisted 
of patients with dysphagia toxicity larger than grade 2 and the other 
group (Gr 1) contained patients with mild or no dysphagia (grade 0 or 
1). The average difference of SUVmax is measured for each of the 
groups, ΔSUVmax. 
-The dose was computed for each esophageal region. We then 
correlated the dose given to each third to the ΔSUVmax on the 
corresponding region. 
Results: The dose delivered to the patients until the second PET/CT 
scan was on average 21 ± 3 Gy.  
-The increase in SUVmax was significantly higher in the severe 
dysphagia group (ΔSUVmax = 0.34 ± 0.66 of increase in Gr 2) than for 
patients without dysphagia toxicity (-0.17 ± 2.1). By using the one-
sided Wilcoxon rank sum test, the p-value was significant (p=0.055).  
-The increase of SUVmax was highest in the most caudal part of the 
esophagus for the patients having severe dysphagia: ΔSUVmax = 0.53 
±0.81 compared to the patients without toxicity: ΔSUVmax = 0.18 ± 
1.3, with a trend towards significance (p-value =0.06).  
-The increase in SUVmax for the middle and cranial parts were not 
significant (large p-values > 0.20).  
Conclusions: Significant increase in SUVmax for patients with severe 
dysphagia was observed. The increase in the caudal third of the 
esophagus was higher for patients with severe dysphagia compared to 
the other parts of the esophagus. A validation study or an extension of 
the cohort patients is however necessary. 
Figure 1. Summary showing for each part of the esophagus the 
difference of ΔSUV(MAX) for each region of the esophagus: its value 
(of increase), standard deviation, p-value and significance of the one-
sided Wilcoxon rank sum test. 
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Purpose/Objective: Novel radiotherapy techniques such as 
stereotactic radiosurgery (SRS), stereotactic body radiation therapy 
(SBRT), high-dose-rate (HDR), brachytherapy boost, and intra-
operative radiotherapy (IORT), use a single or very few, very large 
dose fractions. Furthermore, the total time required to apply a dose 
fraction may be increased, allowing induction and repair of sublethal 
lesions during the treatment. In addition, IORT potentially influences 
subsequent wound healing. This departure from conventional 
fractionated radiotherapy may influence the biological effect in 
several ways. The purpose was to study the influence of high single 
doses, and protracted irradiation, on RBE, repair, and wound healing 
in vitro. 
Materials and Methods: Human MCF7 breast cancer cells, normal skin 
fibroblasts and endothelial cells (HUVEC), and hamster V79 cells, were 
used. Irradiation was performed with 50 kV X-rays from the 
Intrabeam® machine with a 4 cm applicator for tumour-bed 
irradiation (Carl Zeiss Surgical, Oberkochen, Germany) or 6 MV X-rays 
from a linear accelerator. Clonogenic cell survival was determined by 
the colony formation assay; repair halftimes of sublethal damage 
(SLD) were determined from split-dose experiments; DNA double-
strand breaks (DSB) were monitored by phosphorylated histone γH2AX 
foci; cell migration was quantified by the in vitro wound healing 
(scratch) assay. 
Results: The RBE of 50 kV X-rays was increased relative to 6 MV (mean 
1.35; 95% c.i.;1.2-1.5) at 8.1 mm depth in a water-equivalent tumour-
bed phantom (dose rate 15.1 Gy/min) but a decrease with increasing 
dose as predicted by the linear-quadratic (L-Q) formalism was not 
observed. However, RBE was decreased irrespective of dose at the 
lower dose rate of 9.8 Gy/min in 12.7 mm depth. This could be partly 
explained by continuous induction and repair of SLD during protracted 
irradiation. On the other hand, residual γH2AX foci in V79 cells 24h 
after irradiation with 4.7 Gy (equivalent to approximately 6 Gy of 6 
MV X-rays) decreased with decreasing dose rate (25 to 7 Gy/h) in air, 
indicating a possible limiting role of the DSB repair system. Whereas a 
dose of 12 Gy of 6 MV X-rays strongly inactivated fibroblast colony 
formation, migration in the wound healing assay was not inhibited, 
and even slightly stimulated, by irradiation. The cytokine TGF-β1, 
which plays a central role in wound healing, inhibited migration but 
no interaction between irradiation and TGF-β1 was observed. 
Conclusions: The RBE, and effects of repair during protracted dose 
delivery, should be taken into account when assessing biological 
effects of large dose fractions of IORT. However, deviations from the 
dose dependence predicted by the L-Q formalism were observed. 
Unexpectedly, no adverse effect of high-dose irradiation on migration 
was observed in the absence or presence of TGF-β1. Further studies of 
the biological effects of very large dose fractions are warranted. 
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Purpose/Objective: The effects of radio-adaptive response is the 
main interest many studies.The exposure of cell lines to low-dose 
irradiation leads to changes at molecular level which may induce 
adaptive response. Cells and tissues exposure to low doses followed by 
higher irradiation doses is named radioadaptive irradiation. Adaptive 
response can lead to hypersensitivity or radioresistance. The aim of 
this research was to examine the effects of everyday low-dose pre-
irradiation on cell viability in two cell lines: cancer cells and fetal 
lung fibroblasts. 
Materials and Methods: We studied the effect of a low-dose pre-
irradiation (0.03Gy, 0.05Gy and 0.07 Gy), applicated everyday solely 
and also everyday prior to 2.0Gy challenging dose after two hours, on 
